Author:
Proskurina Anastasia S.,Gvozdeva Tatiana S.,Potter Ekaterina A.,Dolgova Evgenia V.,Orishchenko Konstantin E.,Nikolin Valeriy P.,Popova Nelly A.,Sidorov Sergey V.,Chernykh Elena R.,Ostanin Alexandr A.,Leplina Olga Y.,Dvornichenko Victoria V.,Ponomarenko Dmitriy M.,Soldatova Galina S.,Varaksin Nikolay A.,Ryabicheva Tatiana G.,Uchakin Peter N.,Rogachev Vladimir A.,Shurdov Mikhail A.,Bogachev Sergey S.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference39 articles.
1. American Cancer Society. Cancer Facts and Figures 2015. Atlanta: American Cancer Society; 2015.
2. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2007. Bethesda: National Cancer Institute; 2010.
3. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893–907.
4. Cheng YC, Ueno NT. Improvement of survival and prospect of cure in patients with metastatic breast cancer. Breast Cancer. 2012;19(3):191–9.
5. Martin M, Villar A, Sole-Calvo A, Gonzalez R, Massuti B, Lizon J, Camps C, Carrato A, Casado A, Candel MT, Albanell J, Aranda J, Munarriz B, Campbell J, Diaz-Rubio E, GEICAM Group (Spanish Breast Cancer Research Group), Spain. Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group. Ann Oncol. 2003;14(6):833–42.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献